GIRP - European Healthcare Distribution Association

GIRP, the European Healthcare Distribution Association, welcomes the opportunity to contribute to the European Commissions Call for Evidence on the targeted revision of the EU rules for medical devices and in vitro diagnostics.

Please find attached GIRP's contribution to the European Commissions public consultation on the Revision of the EU general pharmaceuticals legislation. GIRP, the European Healthcare Distribution Association, welcomes the revision of the EU General Pharmaceutical Legislation and the opportunity to provide feedback to the European Commission on the published text.

GIRP welcomes the opportunity to comment on the evaluation and revision of the general pharmaceutical legislation by the European Commission (EC). GIRP identifies 4 key areas to improve access to medicines: 1. Ensure through a regulated and enforced framework (with appropriate incentives) the safe, efficient, and fair distribution of medicinal products, and medical devices, to all patients in crisis and non-crisis…

GIRP, the European Healthcare Distribution Association welcomes the opportunity given by the Commission to give feedback on the Regulation on Clean Corporate Vehicles. GIRP represents the national associations of over 500 pharmaceutical full-line wholesalers operating across 33 European countries, alongside major pan-European and international healthcare distribution companies.

GIRP welcomes the Proposal for a directive of the European Parliament and of the Council on the resilience of critical entities and the harmonisation purpose it serves to apply a uniform approach in identifying critical entities, while also accounting for specificities at national level, including varying levels of risk exposure and interdependencies between sectors and over borders.

GIRP welcomes the proposed regulation on a reinforced role for the EMA in crisis preparedness and management for medicinal products and medical devices. GIRP believes that EU coordination is key to addressing the issue of medicine shortages in times of crisis and we are convinced that the EMA is well-fitted to monitor and mitigate potential and actual shortages for the duration of a public health emergency or major…

GIRP welcomes the initiative of the European Commission to adopt legislative and non-legislative measures to implement a flexible and transparent mechanism to strengthen the resilience of the European single market. As a cornerstone of the European Union, the Single Market and the freedom of movements of goods is a key component of the ever closer Union that impregnates the spirit of the Treaties.